-- New offering builds on platform's industry-leading accuracy and sensitivity --
BGI Tech Solutions Co., LTD, (BGI Tech), a subsidiary of BGI, the world's largest genomics organization, announced the global launch of a new human whole exome sequencing service based on Complete Genomics' industry-leading platform.
Complete Genomics, highly regarded in the industry for providing proprietary sequencing technologies with 99.999% accuracy and highly sensitive detection of all types of variants, was acquired by BGI in 2013. More than 15,000 human genomes have been sequenced and analyzed on the Complete Genomics platform to date. BGI, applying its deep genome and exome sequencing expertise, has enriched Complete Genomics' platform further to now enable robust and rapid human whole exome sequencing services that leverage the inherent strengths of that platform.
Whole exome sequencing on Complete Genomics' platform, available beginning today at introductory pricing of only $599 per sample through year-end 2014, guarantees 100X average sequencing depth for target regions and includes analysis for SNP/InDel calling and annotation as well as SNP validation. In addition, BGI Tech provides a dedicated workflow and pipeline addressing cancer study design and challenges, enabling sensitive detection of somatic variants in the presence of tumor heterogeneity.
Yingrui Li, CEO of BGI Tech, stated, "We are pleased to make this extremely accurate platform available to our more than 30,000 customers worldwide and to the global research community. We currently are developing additional applications of this platform, such as transcriptome analysis and genotyping by sequencing, and look forward to announcing their availability soon."
For more information, visit bgitechsolutions.com/complete-genomics-offers.
###
About BGI Tech
BGI Tech, a subsidiary of BGI, the world's largest genomics organization, provides sequencing and bioinformatics service solutions for global biomedical, agricultural, and environmental customers. Equipped with the industry's broadest array of cutting-edge technologies, BGI Tech delivers rapid, cost-effective and high-quality results that enable researchers to achieve scientific breakthroughs. BGI Tech has provided premier services to more than 10,000 research institutes and 30,000 scientific partners, resulting in more than 600 publications, including 100 in top-tier journals such as Nature and Science. For more information visit bgitechsolutions.com.
Contacts
Bicheng Yang, Ph.D.
Public Communication Officer
BGI
+86-755-82639701
[email protected]
www.genomics.cn
Joyce Peng, Ph.D.
Marketing Director
BGI Tech & BGI Americas
+1-626-222-5584
[email protected]
www.bgitechsolutions.com
3rd Mobile Title Based on "The Legend of Mir 2" Universe Features Various Contents such as PvP Battles, Boss Dungeons, Guild System Commemorative Events Include Mission Completion, Gameplay Review Video Production ChuanQi IP, a subsidiary of WEMADE (CEO: Henry Chang), has officially released the blockchain-based idle martial arts RPG, "MIR2M: The Grandmaster," today (2nd). "MIR2M: The Grandmaster" is the third title in the MIR2M series. Based on "The Legend of Mir 2" universe, it tells the story
ฉวนฉี ไอพี จัดกิจกรรมแอร์ดรอปฉลองการเปิดตัวเกม "MIR2M: The Grandmaster"
—
เกมมือถือเกมที่ 3 ในจักรวาล "The Legend of Mir 2" อัดแน่นด้วยคอนเทนต์หลากหลาย ทั...
BingX Wins TradingView Best Crypto Exchange 2023
—
BingX, a global leading crypto exchange, has been awarded Best Crypto Broker/Exchange for three con...
แวนเทจ ได้รับรางวัล "Best-in-Class Social Copy Trading" สองปีซ้อน
—
แวนเทจ (Vantage) หรือ แวนเทจ มาร์เก็ตส์ (Vantage Markets) โบรกเกอร์ระดับโลกผู้ให้บริกา...
Vantage Awarded "Best-in-Class Social Copy Trading" Yet Again
—
Global multi-asset broker, Vantage (or Vantage Markets), is honoured to receive the presti...